LyondellBasell (LYB)
Produces polyolefins, intermediate chemicals and engineered compounds while licensing process technologies.
$59.61
vs last close−0.63 (−1.05%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,625 | 9,929 | 8,304 | 8,678 | 8,604 | 9,497 | 7,677 | 7,658 | 7,727 | 7,091 | 7,197 | 9,177 |
| Cost of revenue | 9,177 | 8,940 | 7,200 | 7,244 | 7,303 | 8,747 | 7,128 | 6,858 | 6,821 | 6,631 | 6,496 | 7,139 |
| Gross profit | 1,448 | 989 | 1,104 | 1,434 | 1,301 | 750 | 549 | 800 | 906 | 460 | 701 | 2,038 |
| 434 | 674 | 453 | 435 | 436 | 1,409 | 435 | 470 | 1,637 | 500 | 462 | 495 | |
| Research & development | 31 | 34 | 32 | 33 | 31 | 39 | 34 | 35 | 34 | 35 | 36 | 34 |
| 378 | 399 | 421 | 407 | 400 | 426 | 401 | 435 | 401 | 465 | 411 | 387 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 411 | 0 |
| Other expenses | 25 | 241 | 0 | −5 | 5 | 944 | 0 | 0 | 1,202 | 0 | 15 | 74 |
| Operating income | 1,014 | 315 | 651 | 999 | 865 | −659 | 114 | 330 | −731 | −40 | 239 | 1,543 |
| −113 | −136 | −108 | 200 | −88 | −219 | −55 | −106 | −117 | −107 | −102 | −735 | |
| Interest income | 37 | 41 | 41 | 37 | 36 | 36 | 30 | 21 | 21 | 0 | 31 | 24 |
| Interest expense | 125 | 121 | 127 | 120 | 118 | 116 | 107 | 163 | 130 | 107 | 130 | 125 |
| Other non-operating income | −12 | 15 | −19 | −320 | −30 | 103 | −52 | −57 | −13 | 0 | −36 | 597 |
| Income before tax | 901 | 179 | 543 | 1,199 | 777 | −878 | 59 | 224 | −848 | −147 | 137 | 808 |
| Income tax expense | 153 | −7 | 110 | 253 | 151 | −265 | 36 | 69 | −19 | −7 | −2 | 236 |
| Net income from continuing operations | 748 | 186 | 433 | 946 | 626 | −613 | 23 | 155 | −829 | −140 | 139 | 572 |
| Discontinued operations | −1 | −1 | 40 | −22 | −53 | 10 | 154 | −40 | −61 | 0 | −14 | −13 |
| Net income | 745 | 183 | 471 | 923 | 570 | −598 | 175 | 114 | −892 | −140 | 125 | 559 |
| EPS, basic | $2.29 | $0.56 | $1.45 | $2.82 | $1.76 | −$1.88 | $0.53 | $0.34 | −$2.77 | −$0.45 | $0.38 | $1.72 |
| EPS, diluted | $2.29 | $0.55 | $1.44 | $2.82 | $1.75 | −$1.87 | $0.53 | $0.34 | −$2.77 | −$0.45 | $0.39 | $1.72 |
| Weighted average shares, basic | 324 | 324 | 325 | 326 | 325 | 325 | 324 | 322 | 326 | 322 | 322 | 323 |
| Weighted average shares, diluted | 325 | 326 | 326 | 326 | 326 | 326 | 324 | 322 | 326 | 322 | 323 | 323 |
| EBITDA | 1,393 | 680 | 1,035 | 1,706 | 1,276 | −373 | 489 | 719 | −368 | 345 | 617 | 1,293 |
| Depreciation & amortization | 367 | 380 | 365 | 387 | 381 | 389 | 323 | 332 | 350 | 385 | 342 | 347 |
| EBIT | 1,026 | 300 | 670 | 1,319 | 895 | −762 | 166 | 387 | −718 | −40 | 275 | 946 |
